We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Encompass Health (EHC) Stock Outpacing Its Medical Peers This Year?
Read MoreHide Full Article
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Encompass Health (EHC - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.
Encompass Health is a member of our Medical group, which includes 973 different companies and currently sits at #8 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Encompass Health is currently sporting a Zacks Rank of #2 (Buy).
Over the past 90 days, the Zacks Consensus Estimate for EHC's full-year earnings has moved 5.1% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Our latest available data shows that EHC has returned about 32.3% since the start of the calendar year. Meanwhile, stocks in the Medical group have lost about 3.2% on average. As we can see, Encompass Health is performing better than its sector in the calendar year.
Another Medical stock, which has outperformed the sector so far this year, is Idexx Laboratories (IDXX - Free Report) . The stock has returned 55.1% year-to-date.
Over the past three months, Idexx Laboratories' consensus EPS estimate for the current year has increased 3.7%. The stock currently has a Zacks Rank #2 (Buy).
To break things down more, Encompass Health belongs to the Medical - Outpatient and Home Healthcare industry, a group that includes 15 individual companies and currently sits at #54 in the Zacks Industry Rank. This group has gained an average of 7.8% so far this year, so EHC is performing better in this area.
On the other hand, Idexx Laboratories belongs to the Medical - Instruments industry. This 83-stock industry is currently ranked #159. The industry has moved -8.5% year to date.
Going forward, investors interested in Medical stocks should continue to pay close attention to Encompass Health and Idexx Laboratories as they could maintain their solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Is Encompass Health (EHC) Stock Outpacing Its Medical Peers This Year?
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Encompass Health (EHC - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.
Encompass Health is a member of our Medical group, which includes 973 different companies and currently sits at #8 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Encompass Health is currently sporting a Zacks Rank of #2 (Buy).
Over the past 90 days, the Zacks Consensus Estimate for EHC's full-year earnings has moved 5.1% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Our latest available data shows that EHC has returned about 32.3% since the start of the calendar year. Meanwhile, stocks in the Medical group have lost about 3.2% on average. As we can see, Encompass Health is performing better than its sector in the calendar year.
Another Medical stock, which has outperformed the sector so far this year, is Idexx Laboratories (IDXX - Free Report) . The stock has returned 55.1% year-to-date.
Over the past three months, Idexx Laboratories' consensus EPS estimate for the current year has increased 3.7%. The stock currently has a Zacks Rank #2 (Buy).
To break things down more, Encompass Health belongs to the Medical - Outpatient and Home Healthcare industry, a group that includes 15 individual companies and currently sits at #54 in the Zacks Industry Rank. This group has gained an average of 7.8% so far this year, so EHC is performing better in this area.
On the other hand, Idexx Laboratories belongs to the Medical - Instruments industry. This 83-stock industry is currently ranked #159. The industry has moved -8.5% year to date.
Going forward, investors interested in Medical stocks should continue to pay close attention to Encompass Health and Idexx Laboratories as they could maintain their solid performance.